An essential role for the association of CD47 to SHPS-1 in skeletal remodeling

Journal of Bone and Mineral Research

Volumn 26, Issue 9, 2011, Pages 2068-2081

  Maile, Laura A ^a   Demambro, Victoria E ^b   Wai, Christine ^a   Aday, Ariel W ^a   Capps, Byron E ^a   Beamer, Wesley G ^c   Rosen, Clifford J ^b   Clemmons, David R ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b Maine Medical Center Research Institute   (United States)

^c JACKSON LABORATORY   (United States)

Author keywords

BONE; BONE RESORPTION; NON MUSCLE CELL MYOSIN IIA; OSTEOBLAST; OSTEOCLAST; SHP 1

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; BETA CARBOXY TERMINAL TELOPEPTIDE; CARBOXY TERMINAL TELOPEPTIDE; CD47 ANTIGEN; MYOSIN IIA; OSTEOCLAST DIFFERENTIATION FACTOR; PROCOLLAGEN; PROCOLLAGEN TYPE 1 AMINO TERMINAL PROPEPTIDE; PROTEIN TYROSINE PHOSPHATASE SHP 1; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; SOMATOMEDIN C; TARTRATE RESISTANT ACID PHOSPHATASE 5B; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; BODY COMPOSITION; BONE CHARACTERISTICS AND FUNCTIONS; BONE DENSITY; BONE EROSION; BONE MARROW CELL; BONE MINERAL; BONE REMODELING; BONE TURNOVER; BONE VOLUME; CELL COUNT; CELL DIFFERENTIATION; CELL MATURATION; CONTROLLED STUDY; CORTICAL BONE; ENZYME PHOSPHORYLATION; FEMALE; FEMUR; MALE; MICRO-COMPUTED TOMOGRAPHY; MORPHOMETRICS; MOUSE; MUSCULOSKELETAL SYSTEM PARAMETERS; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOBLASTOGENESIS; OSTEOCLAST; OSTEOCLASTOGENESIS; OSTEOLYSIS; PHENOTYPE; PROTEIN DEPHOSPHORYLATION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; STROMA CELL; TRABECULAR BONE; WESTERN BLOTTING; WILD TYPE;

AGING; ANIMALS; ANTIGENS, CD47; BIOLOGICAL MARKERS; BODY COMPOSITION; BONE REMODELING; CELL DIFFERENTIATION; FEMALE; FEMUR; HUMANS; MALE; MICE; OSTEOBLASTS; OSTEOCLASTS; OSTEOGENESIS; PHENOTYPE; PROTEIN BINDING; RANK LIGAND; RECEPTORS, IMMUNOLOGIC; TOMOGRAPHY, X-RAY COMPUTED;

EID: 80051955959     PISSN: 08840431     EISSN: 15234681     Source Type: Journal    
DOI: 10.1002/jbmr.441     Document Type: Article

References (29)

1. Mocsai A, Humphrey MB, Ziffle JA, et al. The immunomodulatory adapter proteins DAP12 and Fc receptor gamma-chain (FcRγ) regulate development of functional osteoclasts through the Syk tyrosine kinase. Proc Natl Acad Sci USA. 2004; 101: 6158-6163. (Pubitemid 38520544)
2. Vignery A,. Macrophage fusion: the making of osteoclasts and giant cells. J Exp Med. 2005; 202: 337-340. (Pubitemid 41126949)
3. Jiang P, Lagenaur CF, Narayanan V,. Integrin-associated protein is a ligand for the P84 neural adhesion molecule. J Biol Chem. 1999; 274: 559-562.
4. Seiffert M, Cant C, Chen Z, et al. Human signal-regulatory protein is expressed on normal, but not on subsets of leukemic myeloid cells and mediates cellular adhesion involving its counterreceptor CD47. Blood. 1999; 94: 3633-3643.
5. Vernon-Wilson EF, Kee WJ, Willis AC, et al. CD47 is a ligand for rat macrophage membrane signal regulatory protein SIRP (OX41) and human SIRPα1. Eur J Immunol. 2000; 30: 2130-2137. (Pubitemid 30655751)
6. Rosales C, Gresham HD, Brown EJ,. Expression of the 50-kDa integrin-associated protein on myeloid cells and erythrocytes. J Immunol. 1992; 149: 2759-2764.
7. Oldenborg PA, et al. Role of CD47 as a marker of self on red blood cells. Science. 2000; 288: 2051-2054.
8. Fujioka Y, et al. A novel membrane glycoprotein, SHPS-1, that binds the SH2-domain-containing protein tyrosine phosphatase SHP-2 in response to mitogens and cell adhesion. Mol Cell Biol. 1996; 16: 6887-6899. (Pubitemid 26389748)
9. Tsai RK, Discher DE,. Inhibition of "self" engulfment through deactivation of myosin-II at the phagocytic synapse between human cells. J Cell Biol. 2008; 180: 989-1003. (Pubitemid 351398424)
10. Lundberg P, et al. Osteoclast formation is strongly reduced both in vivo and in vitro in the absence of CD47/SIRPalpha-interaction. Biochem Biophys Res Commun. 2007; 352: 444-448. (Pubitemid 44838507)
11. Maile LA, Clemmons DR,. Integrin-associated protein binding domain of thrombospondin-1 enhances insulin-like growth factor-I receptor signaling in vascular smooth muscle cells. Circ Res. 2003; 93: 925-931. (Pubitemid 37433230)
12. Maile LA, et al. Glucose Regulation of Integrin-Associated Protein Cleavage Controls the Response of Vascular Smooth Muscle Cells to Insulin-Like Growth Factor-I. Mol Endocrinol. 2008; 22: 1226-1237. (Pubitemid 351629621)
13. Maile LA, et al. Insulin-like growth factor-I signaling in smooth muscle cells is regulated by ligand binding to the 177CYDMKTTC184 sequence of the beta3-subunit of alphaVbeta3. Mol Endocrinol. 2006; 20: 405-413. (Pubitemid 43152513)
14. DeMambro VE, et al. Gender-specific changes in bone turnover and skeletal architecture in igfbp-2-null mice. Endocrinology. 2008; 149: 2051-2061.
15. Delahunty KM, et al. Congenic mice provide in vivo evidence for a genetic locus that modulates serum insulin-like growth factor-I and bone acquisition. Endocrinology. 2006; 147: 3915-3923. (Pubitemid 44079397)
16. Beamer WG, et al. Genetic dissection of mouse distal chromosome 1 reveals three linked BMD QTLs with sex-dependent regulation of bone phenotypes. J Bone Miner Res. 2007; 22: 1187-1196. (Pubitemid 351339701)
17. Rydziel S, et al. Nephroblastoma overexpressed (Nov) inhibits osteoblastogenesis and causes osteopenia. J Biol Chem. 2007; 282: 19762-19772. (Pubitemid 47100103)
18. Parfitt AM, et al. Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res. 1987; 2: 595-610.
19. Maile LA, Badley-Clarke J, Clemmons DR,. The association between integrin-associated protein and SHPS-1 regulates insulin-like growth factor-I receptor signaling in vascular smooth muscle cells. Mol Biol Cell. 2003; 14: 3519-3528. (Pubitemid 37151605)
20. Maile LA, Allen LB, Hanzaker CF, Gollahon KA, Dunbar P, Clemmons DR,. Glucose regulation of thrombospondin and its role in the modulation of smooth muscle cell proliferation. Exp Diabetes Res. 2010; 2010. pii: 617052.
21. Wang D, Christensen K, Chawla K, Xiao G, Krebsbach PH, Franceschi RT,. Isolation and characterization of MC3T3-El preosteoblast subclones with distinct in vitro and in vivo differentiation/mineralization potential. J Bone Mineral Res. 1999; 14: 893-8903.
22. Uluckan O, et al. CD47 regulates bone mass and tumor metastasis to bone. Cancer Res. 2009; 69: 3196-3204.
23. Saginario C, et al. MFR, a putative receptor mediating the fusion of macrophages. Mol Cell Biol. 1998; 18: 6213-6223. (Pubitemid 28500512)
24. Han X, et al. CD47, a ligand for the macrophage fusion receptor, participates in macrophage multinucleation. J Biol Chem. 2000; 275: 37984-37992. (Pubitemid 32004920)
25. McMichael BK, Wysolmerski RB, Lee BS,. Regulated proteolysis of nonmuscle myosin IIA stimulates osteoclast fusion. J Biol Chem. 2009; 284: 12266-12275.
26. Ling Y, et al. Role of SHPS-1 in the regulation of insulin-like growth factor I-stimulated Shc and mitogen-activated protien kinase activation in vascular smooth muscle cells. Mol Biol Cell. 2005; 16: 3353-3364. (Pubitemid 40962604)
27. Papachroni K, et al. Mechanotransduction in osteoclast regulation and bone disease. Trends Mol Med. 2009; 15: 208-216.
28. Lieskovska J, et al. The role of Src kinase in insulin-like growth factor-depencent mitogenic signaling in vascular smooth muscle cells. J Biol Chem. 2006; 281: 25041-25053. (Pubitemid 44401892)
29. Rangaswami H, et al. Cyclic GMP and protein kinase G control a Src-containing mechanosome in osteoblasts. Sci Signaling. 2010; 153: ra91.